Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 20866 AL 20880

A mechanistic survey of Alzheimer's disease

Tang Y, Zhang D, Gong X, Zheng J.

Biophys Chem. 2022 Feb;281:106735. doi: 10.1016/j.bpc.2021.106735. Epub 2021 Nov 30.

[Sleep disorders in patients with a neurocognitive disorder]

Moderie C, Carrier J, Dang-Vu TT.

Encephale. 2022 Jun;48(3):325-334. doi: 10.1016/j.encep.2021.08.014. Epub 2021 Dec 14.

Targeting disorders in unstructured and structured proteins in various diseases

Choudhary S, Lopus M, Hosur RV.

Biophys Chem. 2022 Feb;281:106742. doi: 10.1016/j.bpc.2021.106742. Epub 2021 Dec 11.

Melatonin hormone as a therapeutic weapon against neurodegenerative diseases

Asefy Z, Khusro A, Mammadova S, Hoseinnejhad S, Eftekhari A, Alghamdi S, Dablool AS, Almehmadi M, Kazemi E, Sahibzada MUK.

Cell Mol Biol (Noisy-le-grand). 2021 Nov 25;67(3):99-106. doi: 10.14715/cmb/2021.67.3.13.

Possible association between PM(2.5) and neurodegenerative diseases: A systematic review

Cristaldi A, Fiore M, Oliveri Conti G, Pulvirenti E, Favara C, Grasso A, Copat C, Ferrante M.

Environ Res. 2022 May 15;208:112581. doi: 10.1016/j.envres.2021.112581. Epub 2021 Dec 31.

Gut Microbiota: A Key Regulator in the Effects of Environmental Hazards on Modulates Insulin Resistance

Huang R.

Front Cell Infect Microbiol. 2022 Jan 17;11:800432. doi: 10.3389/fcimb.2021.800432. eCollection 2021.

Role of the gut microbiota in the development of various neurological diseases

Castillo-Álvarez F, Marzo-Sola ME.

Neurologia (Engl Ed). 2022 Jul-Aug;37(6):492-498. doi: 10.1016/j.nrleng.2019.03.026. Epub 2021 May 25.

Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia

Kawakatsu S, Kobayashi R, Hayashi H, Morioka D, Utsunomiya A, Kabasawa T, Ohe R, Otani K.

Neuropathology. 2021 Dec;41(6):427-449. doi: 10.1111/neup.12765. Epub 2021 Nov 23.

De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report

Agüero P, Sainz MJ, Téllez R, Lorda I, Ávila A, García-Ribas G, Rodríguez PP, Gómez-Tortosa E.

J Alzheimers Dis. 2021;83(3):1011-1016. doi: 10.3233/JAD-210420.

Recent Advances in the Potential of Cannabinoids for Neuroprotection in Alzheimer's, Parkinson's, and Huntington's Diseases

Pérez-Olives C, Rivas-Santisteban R, Lillo J, Navarro G, Franco R.

Adv Exp Med Biol. 2021;1264:81-92. doi: 10.1007/978-3-030-57369-0_6.

Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?

Rahimian R, Béland LC, Sato S, Kriz J.

Med Res Rev. 2021 Jul;41(4):2582-2589. doi: 10.1002/med.21784. Epub 2021 Mar 18.

Role of connexins in neurodegenerative diseases (Review)

Xing J, Xu C.

Mol Med Rep. 2021 May;23(5):395. doi: 10.3892/mmr.2021.12034. Epub 2021 Mar 24.

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease

Kim J.

Int J Mol Sci. 2021 Mar 13;22(6):2929. doi: 10.3390/ijms22062929.

Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease

Okazawa H.

Neuropathology. 2021 Apr;41(2):93-98. doi: 10.1111/neup.12738.

Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist

Oldan JD, Jewells VL, Pieper B, Wong TZ.

AJNR Am J Neuroradiol. 2021 Jun;42(6):998-1007. doi: 10.3174/ajnr.A7079. Epub 2021 Apr 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias